BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38030079)

  • 21. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
    Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
    Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy.
    Wang J; Lian CL; Zheng H; Lin LE; Yu YF; Lin Q; Wu SG
    Oral Oncol; 2020 Dec; 111():104921. PubMed ID: 32763779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies.
    Xu Y; Liu Y; Wang Z; Wang J; Zhang J; Chen X; Wu R; Liu Q; Qu Y; Wang K; Huang X; Luo J; Gao L; Xu G; Zhang Y; Yi J
    Radiat Oncol; 2022 Jan; 17(1):13. PubMed ID: 35062991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
    So N; McDowell LJ; Lu L; Xu W; Rock K; Waldron J; Bernstein LJ; Chan HB; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):134-145. PubMed ID: 31568813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-induced functional connectivity alterations in nasopharyngeal carcinoma patients with radiotherapy.
    Ma Q; Wu D; Zeng LL; Shen H; Hu D; Qiu S
    Medicine (Baltimore); 2016 Jul; 95(29):e4275. PubMed ID: 27442663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated Risk of Premature Ischemic Stroke in 5-Year Survivors of Nasopharyngeal Carcinoma.
    Chen MC; Kuan FC; Huang SF; Lu CH; Chen PT; Huang CE; Wang TY; Chen CC; Lee KD
    Oncologist; 2019 Sep; 24(9):e891-e897. PubMed ID: 30898891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of changes in psychological resilience during treatment with intensity-modulated radiotherapy on nasopharyngeal carcinoma patients: a prospective study.
    Lu N; Qin T; Hu W
    Ann Palliat Med; 2022 Jan; 11(1):123-134. PubMed ID: 35144404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
    BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and neuropsychiatric impairment in cerebral radionecrosis patients after radiotherapy of nasopharyngeal carcinoma.
    Wu X; Gu M; Zhou G; Xu X; Wu M; Huang H
    BMC Neurol; 2014 Jan; 14():10. PubMed ID: 24418214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
    Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
    Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
    Fan CY; Lin CS; Chao HL; Huang WY; Su YF; Lin KT; Tsai IJ; Kao CH
    Radiother Oncol; 2017 Jun; 123(3):394-400. PubMed ID: 28532605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.
    MD Anderson Head Neck Cancer Symptom Working Group
    Radiother Oncol; 2019 Apr; 133():35-42. PubMed ID: 30935579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote assessment of cognition and quality of life following radiotherapy for nasopharyngeal carcinoma: deep-learning-based predictive models and MRI correlates.
    Voon NS; Manan HA; Yahya N
    J Cancer Surviv; 2023 Apr; ():1-12. PubMed ID: 37010777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
    Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance.
    Wang J; Huang X; Sun S; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Xiao J; Gao L; Xu G; Hu C; Li YX; Yi J
    Cancer Med; 2021 Jun; 10(11):3613-3621. PubMed ID: 33960136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106).
    Ha B; Cho KH; Moon SH; Lee CG; Keum KC; Kim YS; Wu HG; Kim JH; Ahn YC; Oh D; Noh JM; Lee JH; Kim SH; Kim WT; Oh YT; Kang MK; Kim JH; Kim JY; Cho MJ; Kay CS; Choi JH
    Cancer Res Treat; 2019 Jan; 51(1):12-23. PubMed ID: 29397658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.